Etanercept Market Size, Share, Growth Analysis, Forecast Report 2023-2030
Etanercept Market By Drug Type (Enbrel, Benepali, and Others), By Application (Juvenile Idiopathic Arthritis, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Others), and By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 - 2030
Category: Healthcare Report Format : PDF
Pages: 233 Report Code: ZMR-4989
Published Date: Aug-2023 Status : Published
| Market Size in 2022 | Market Forecast in 2030 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 16.1 Billion | USD 31.1Billion | 4% | 2022 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Etanercept Market, (2023 - 2030) (USD Billion)
- 2.2 Global Etanercept Market : snapshot
- Chapter 3. Global Etanercept Market - Industry Analysis
- 3.1 Etanercept Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 A rise in the cases of spondylitis and rheumatoid arthritis will spike the global market growth
- 3.3 Market Restraints
- 3.3.1. Strict laws related to safety over consumption of drugs can abridge their demand in the healthcare sector
- 3.4 Market Opportunities
- 3.4.1. An increase in healthcare investments will open new facets of growth for the global market by 2030
- 3.5 Market Challenges
- 3.5.1. Restrictions on the prescription of drugs in a few countries can create barricades in the global industry surge over the forecast period
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Drug Type
- 3.7.2 Market attractiveness analysis By Application
- Chapter 4. Global Etanercept Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Etanercept Market: company market share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Etanercept Market - Drug Type Analysis
- 5.1 Global Etanercept Market overview: By Drug Type
- 5.1.1 Global Etanercept Market share, By Drug Type, 2022 and 2030
- 5.2 Enbrel
- 5.2.1 Global Etanercept Market by Enbrel, 2023 - 2030 (USD Billion)
- 5.3 Benepali
- 5.3.1 Global Etanercept Market by Benepali, 2023 - 2030 (USD Billion)
- 5.4 Others
- 5.4.1 Global Etanercept Market by Others, 2023 - 2030 (USD Billion)
- 5.1 Global Etanercept Market overview: By Drug Type
- Chapter 6. Global Etanercept Market - Application Analysis
- 6.1 Global Etanercept Market overview: By Application
- 6.1.1 Global Etanercept Market share, By Application, 2022 and 2030
- 6.2 Juvenile Idiopathic Arthritis
- 6.2.1 Global Etanercept Market by Juvenile Idiopathic Arthritis, 2023 - 2030 (USD Billion)
- 6.3 Rheumatoid Arthritis
- 6.3.1 Global Etanercept Market by Rheumatoid Arthritis, 2023 - 2030 (USD Billion)
- 6.4 Psoriatic Arthritis
- 6.4.1 Global Etanercept Market by Psoriatic Arthritis, 2023 - 2030 (USD Billion)
- 6.5 Ankylosing Spondylitis
- 6.5.1 Global Etanercept Market by Ankylosing Spondylitis, 2023 - 2030 (USD Billion)
- 6.6 Others
- 6.6.1 Global Etanercept Market by Others, 2023 - 2030 (USD Billion)
- 6.1 Global Etanercept Market overview: By Application
- Chapter 7. Etanercept Market - Regional Analysis
- 7.1 Global Etanercept Market Regional Overview
- 7.2 Global Etanercept Market Share, by Region, 2022 & 2030 (USD Billion)
- 7.3. North America
- 7.3.1 North America Etanercept Market, 2023 - 2030 (USD Billion)
- 7.3.1.1 North America Etanercept Market, by Country, 2023 - 2030 (USD Billion)
- 7.3.1 North America Etanercept Market, 2023 - 2030 (USD Billion)
- 7.4 North America Etanercept Market, by Drug Type, 2023 - 2030
- 7.4.1 North America Etanercept Market, by Drug Type, 2023 - 2030 (USD Billion)
- 7.5 North America Etanercept Market, by Application, 2023 - 2030
- 7.5.1 North America Etanercept Market, by Application, 2023 - 2030 (USD Billion)
- 7.4. Europe
- 7.4.2 Europe Etanercept Market, 2023 - 2030 (USD Billion)
- 7.4.2.1 Europe Etanercept Market, by Country, 2023 - 2030 (USD Billion)
- 7.4.2 Europe Etanercept Market, 2023 - 2030 (USD Billion)
- 7.4 Europe Etanercept Market, by Drug Type, 2023 - 2030
- 7.4.1 Europe Etanercept Market, by Drug Type, 2023 - 2030 (USD Billion)
- 7.5 Europe Etanercept Market, by Application, 2023 - 2030
- 7.5.1 Europe Etanercept Market, by Application, 2023 - 2030 (USD Billion)
- 7.5. Asia Pacific
- 7.5.3 Asia Pacific Etanercept Market, 2023 - 2030 (USD Billion)
- 7.5.3.1 Asia Pacific Etanercept Market, by Country, 2023 - 2030 (USD Billion)
- 7.5.3 Asia Pacific Etanercept Market, 2023 - 2030 (USD Billion)
- 7.4 Asia Pacific Etanercept Market, by Drug Type, 2023 - 2030
- 7.4.1 Asia Pacific Etanercept Market, by Drug Type, 2023 - 2030 (USD Billion)
- 7.5 Asia Pacific Etanercept Market, by Application, 2023 - 2030
- 7.5.1 Asia Pacific Etanercept Market, by Application, 2023 - 2030 (USD Billion)
- 7.6. Latin America
- 7.6.4 Latin America Etanercept Market, 2023 - 2030 (USD Billion)
- 7.6.4.1 Latin America Etanercept Market, by Country, 2023 - 2030 (USD Billion)
- 7.6.4 Latin America Etanercept Market, 2023 - 2030 (USD Billion)
- 7.4 Latin America Etanercept Market, by Drug Type, 2023 - 2030
- 7.4.1 Latin America Etanercept Market, by Drug Type, 2023 - 2030 (USD Billion)
- 7.5 Latin America Etanercept Market, by Application, 2023 - 2030
- 7.5.1 Latin America Etanercept Market, by Application, 2023 - 2030 (USD Billion)
- 7.7. The Middle-East and Africa
- 7.7.5 The Middle-East and Africa Etanercept Market, 2023 - 2030 (USD Billion)
- 7.7.5.1 The Middle-East and Africa Etanercept Market, by Country, 2023 - 2030 (USD Billion)
- 7.7.5 The Middle-East and Africa Etanercept Market, 2023 - 2030 (USD Billion)
- 7.4 The Middle-East and Africa Etanercept Market, by Drug Type, 2023 - 2030
- 7.4.1 The Middle-East and Africa Etanercept Market, by Drug Type, 2023 - 2030 (USD Billion)
- 7.5 The Middle-East and Africa Etanercept Market, by Application, 2023 - 2030
- 7.5.1 The Middle-East and Africa Etanercept Market, by Application, 2023 - 2030 (USD Billion)
- Chapter 8. Company Profiles
- 8.1 Pfizer Inc.
- 8.1.1 Overview
- 8.1.2 Financials
- 8.1.3 Product Portfolio
- 8.1.4 Business Strategy
- 8.1.5 Recent Developments
- 8.2 GlaxoSmithKline Pharmaceuticals Ltd.
- 8.2.1 Overview
- 8.2.2 Financials
- 8.2.3 Product Portfolio
- 8.2.4 Business Strategy
- 8.2.5 Recent Developments
- 8.3 Samsung Bioepis Co. Ltd.
- 8.3.1 Overview
- 8.3.2 Financials
- 8.3.3 Product Portfolio
- 8.3.4 Business Strategy
- 8.3.5 Recent Developments
- 8.4 Novartis International AG
- 8.4.1 Overview
- 8.4.2 Financials
- 8.4.3 Product Portfolio
- 8.4.4 Business Strategy
- 8.4.5 Recent Developments
- 8.5 Immunex Corporation
- 8.5.1 Overview
- 8.5.2 Financials
- 8.5.3 Product Portfolio
- 8.5.4 Business Strategy
- 8.5.5 Recent Developments
- 8.6 F. Hoffmann-La Roche Ltd.
- 8.6.1 Overview
- 8.6.2 Financials
- 8.6.3 Product Portfolio
- 8.6.4 Business Strategy
- 8.6.5 Recent Developments
- 8.7 Takeda Pharmaceutical Company Ltd.
- 8.7.1 Overview
- 8.7.2 Financials
- 8.7.3 Product Portfolio
- 8.7.4 Business Strategy
- 8.7.5 Recent Developments
- 8.8 Cipla Limited
- 8.8.1 Overview
- 8.8.2 Financials
- 8.8.3 Product Portfolio
- 8.8.4 Business Strategy
- 8.8.5 Recent Developments
- 8.9 Johnson & Johnson
- 8.9.1 Overview
- 8.9.2 Financials
- 8.9.3 Product Portfolio
- 8.9.4 Business Strategy
- 8.9.5 Recent Developments
- 8.10 Celltrion Inc.
- 8.10.1 Overview
- 8.10.2 Financials
- 8.10.3 Product Portfolio
- 8.10.4 Business Strategy
- 8.10.5 Recent Developments
- 8.11 and others.
- 8.11.1 Overview
- 8.11.2 Financials
- 8.11.3 Product Portfolio
- 8.11.4 Business Strategy
- 8.11.5 Recent Developments
- 8.1 Pfizer Inc.
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Etanercept Market, 2023 - 2030 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Etanercept Market attractiveness, By Drug Type
- 6. Global Etanercept Market attractiveness, By Application
- 7. Global Etanercept Market share by Drug Type, 2023 and 2030 (USD Billion)
- 8. Global Etanercept Market by Enbrel, 2023 - 2030 (USD Billion)
- 9. Global Etanercept Market by Benepali, 2023 - 2030 (USD Billion)
- 10. Global Etanercept Market by Others, 2023 - 2030 (USD Billion)
- 11. Global Etanercept Market share by Application, 2023 and 2030 (USD Billion)
- 12. Global Etanercept Market by Juvenile Idiopathic Arthritis, 2023 - 2030 (USD Billion)
- 13. Global Etanercept Market by Rheumatoid Arthritis, 2023 - 2030 (USD Billion)
- 14. Global Etanercept Market by Psoriatic Arthritis, 2023 - 2030 (USD Billion)
- 15. Global Etanercept Market by Ankylosing Spondylitis, 2023 - 2030 (USD Billion)
- 16. Global Etanercept Market by Others, 2023 - 2030 (USD Billion)
- 17. Global Etanercept Market share, by Region, 2023 and 2030
- 18. North America Etanercept Market, 2023 - 2030 (USD Billion)
- 19. Europe Etanercept Market, 2023 - 2030 (USD Billion)
- 20. Asia Pacific Etanercept Market, 2023 - 2030 (USD Billion)
- 21. Latin America Etanercept Market, 2023 - 2030 (USD Billion)
- 22. The Middle-East and Africa Etanercept Market, 2023 - 2030 (USD Billion)
Table Of Tables
- 1. Global Etanercept Market: Snapshot
- 2. Drivers of the Etanercept Market: impact analysis
- 3. North America Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 4. North America Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 5. U.S. Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 6. U.S. Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 7. Canada Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 8. Canada Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 9. Europe Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 10. Europe Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 11. Germany Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 12. Germany Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 13. France Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 14. France Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 15. U.K. Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 16. U.K. Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 17. Italy Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 18. Italy Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 19. Spain Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 20. Spain Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 21. Rest of Europe Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 22. Rest of Europe Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 23. Asia Pacific Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 24. Asia Pacific Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 25. China Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 26. China Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 27. Japan Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 28. Japan Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 29. India Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 30. India Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 31. South Korea Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 32. South Korea Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 33. South-East Asia Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 34. South-East Asia Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 35. Rest of Asia Pacific Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 36. Rest of Asia Pacific Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 37. Latin America Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 38. Latin America Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 39. Brazil Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 40. Brazil Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 41. Mexico Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 42. Mexico Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 43. Rest of Latin America Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 44. Rest of Latin America Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 45. The Middle-East and Africa Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 46. The Middle-East and Africa Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 47. GCC Countries Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 48. GCC Countries Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 49. South Africa Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 50. South Africa Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
- 51. Rest of Middle-East Africa Etanercept Market revenue, By Drug Type, 2023 - 2030 (USD Billion)
- 52. Rest of Middle-East Africa Etanercept Market revenue, By Application, 2023 - 2030 (USD Billion)
Methodology
FrequentlyAsked Questions
Etanercept is a biopharmaceutical that is used to treat autoimmune disorders such as psoriatic arthritis, plaque psoriasis, juvenile idiopathic arthritis, rheumatoid arthritis, and ankylosing spondylitis.
The global etanercept market growth is owing to a rise in lifestyle-related diseases such as diabetes, obesity, and high blood pressure.
According to a study, the global etanercept industry size was $16.1 billion in 2022 and is projected to reach $31.1 billion by the end of 2030.
The global etanercept market is anticipated to record a CAGR of nearly 4% from 2023 to 2030.
The North American etanercept industry is set to register the highest CAGR over the forecasting timeline owing to the presence of key companies in countries such as the U.S., the rapid uptake of new treatments, and the accessibility of modern treatment options available in the region.
The global etanercept market is led by players such as Pfizer Inc., GlaxoSmithKline Pharmaceuticals Ltd., Samsung Bioepis Co. Ltd., Novartis International AG, Immunex Corporation, F. Hoffmann-La Roche Ltd., Takeda Pharmaceutical Company Ltd., Cipla Limited, Johnson & Johnson, and Celltrion Inc.
The etanercept market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed